{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:12:59Z","timestamp":1793229179282,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010571","name":"Federal Ministry of Education and Research Berlin Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KA1613"],"award-info":[{"award-number":["01KA1613"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jinf.2024.106379","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T19:18:27Z","timestamp":1736018307000},"page":"106379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis"],"prefix":"10.1016","volume":"90","author":[{"given":"Daniel Adon","family":"Mapamba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Sabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieth","family":"Lalashowi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elingarami","family":"Sauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joram","family":"Buza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willyhelmina","family":"Olomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bariki","family":"Mtafya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kibona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Bakuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rachow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-3915","authenticated-orcid":false,"given":"Kavindhran","family":"Velen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyanda E.","family":"Ntinginya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6152-5183","authenticated-orcid":false,"given":"Robert S.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.106379_bib1","unstructured":"World Health Organization, Global Tuberculosis Report, 1st ed. Geneva: World Health Organization, 2020. [Online]. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports."},{"key":"10.1016\/j.jinf.2024.106379_bib2","doi-asserted-by":"crossref","first-page":"e1679","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae","volume":"9","author":"Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jinf.2024.106379_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0954-6111(89)80031-9","article-title":"Chronic obstructive airways disease following treated pulmonary tuberculosis","volume":"83","author":"Willcox","year":"1989","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2024.106379_bib4","doi-asserted-by":"crossref","first-page":"e0211355","DOI":"10.1371\/journal.pone.0211355","article-title":"The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: a modelling study","volume":"14","author":"Romanowski","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2024.106379_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","article-title":"Host-directed immunotherapy of viral and bacterial infections: past, present and future","volume":"23","author":"Wallis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jinf.2024.106379_bib6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106379_bib7","doi-asserted-by":"crossref","first-page":"e26254","DOI":"10.1371\/journal.pone.0026254","article-title":"Evidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosis","volume":"6","author":"Palanisamy","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2024.106379_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-016-0872-7","article-title":"N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions","volume":"16","author":"Amaral","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jinf.2024.106379_bib9","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1073\/pnas.1704376114","article-title":"Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis","volume":"114","author":"Vilch\u00e8ze","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jinf.2024.106379_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01703-20","article-title":"The promises and limitations of N- acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs","volume":"65","author":"Vilch\u00e8ze","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2024.106379_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00592-22","article-title":"Moxifloxacin-mediated killing of Mycobacterium tuberculosis involves respiratory downshift, reductive stress, and accumulation of reactive oxygen species","volume":"66","author":"Shee","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2024.106379_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300332","article-title":"Adjunctive N-acetylcysteine and lung function in pulmonary tuberculosis","volume":"3","author":"Wallis","year":"2024","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jinf.2024.106379_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-018-0777-3","article-title":"TB sequel: Incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol","volume":"19","author":"Rachow","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jinf.2024.106379_bib14","first-page":"68","article-title":"Diagnostic standards and classification of tuberculosis","volume":"6","author":"Falk","year":"1969","journal-title":"National Tuberculosis and Respiratory Disease Association"},{"key":"10.1016\/j.jinf.2024.106379_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/bdd.2510110205","article-title":"Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man","volume":"11","author":"Borgstr\u00f6m","year":"1990","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jinf.2024.106379_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/655471","article-title":"Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers","volume":"202","author":"Wallis","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2024.106379_bib17","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/IAI.73.5.2595-2601.2005","article-title":"Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity","volume":"73","author":"Janulionis","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2024.106379_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200701-007OC","article-title":"A single dose of vitamin D enhances immunity to mycobacteria","volume":"176","author":"Martineau","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2024.106379_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CDLI.9.4.901-907.2002","article-title":"Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis","volume":"9","author":"Cheon","year":"2002","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2024.106379_bib20","doi-asserted-by":"crossref","first-page":"e94462","DOI":"10.1371\/journal.pone.0094462","article-title":"Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis","volume":"9","author":"Wallis","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jinf.2024.106379_bib21","unstructured":"W. H. O., World Health Organization, \u201cGlobal tuberculosis report,\u201d Treatment of Tuberculosis. Guidelines, 4th ed., 2010, Geneva: WHO, 103\u2013114."},{"key":"10.1016\/j.jinf.2024.106379_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/clinchem\/48.5.742","article-title":"Blood glutathione disulfide: in vivo factor or in vitro artifact?","volume":"48","author":"Rossi","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.jinf.2024.106379_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0009-8981(96)06423-6","article-title":"Evaluation of reference values for erythrocyte glutathione","volume":"256","author":"\u0130nal","year":"1996","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jinf.2024.106379_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.smim.2014.04.003","article-title":"Tumor necrosis factor alpha in mycobacterial infection","volume":"26","author":"Dorhoi","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jinf.2024.106379_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/infdis\/174.4.727","article-title":"Pentoxifylline therapy in human immunodeficiency virus--seropositive persons with tuberculosis: a randomized, controlled trial","volume":"174","author":"Wallis","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2024.106379_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/427995","article-title":"Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda","volume":"191","author":"Mayanja-Kizza","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2024.106379_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jinf.2024.106379_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12275-016-5534-9","article-title":"Antibacterial effects of N-acetylcysteine against endodontic pathogens","volume":"54","author":"Moon","year":"2016","journal-title":"J Microbiol"},{"key":"10.1016\/j.jinf.2024.106379_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tube.2003.12.007","article-title":"The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses","volume":"84","author":"Kendall","year":"2004","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2024.106379_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.5.2.144","article-title":"Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis: results of simultaneous sensitivity tests in liquid and on solid media","volume":"5","author":"Mitchison","year":"1950","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2024.106379_bib31","first-page":"128","article-title":"A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"12","author":"Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2024.106379_bib32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/319679","article-title":"A whole blood bactericidal assay for tuberculosis","volume":"183","author":"Wallis","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2024.106379_bib33","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A four-month gatifloxacin-containing regimen for treating tuberculosis","volume":"371","author":"Merle","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106379_bib34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"371","author":"Gillespie","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jinf.2024.106379_bib35","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-month rifapentine regimens with or without moxifloxacin for tuberculosis","volume":"384","author":"Dorman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106379_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12916-016-0597-3","article-title":"A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)","volume":"14","author":"Phillips","year":"2016","journal-title":"BMC Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324003141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324003141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:30:00Z","timestamp":1762248600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324003141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0163445324003141"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106379","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106379"}}